DS - Keppra
DS - Keppra
DS - Keppra
: ___________________ Impression/Diagnosis: __________________________ Age: ____________________________________________ Chief Complaints: __________________ Attending Physician: __________________________
Drugs
Classification/Mechanis m of Action
Indication
Contraindication
Generic: levetiracetam Brand: Keppra Dosage: 500mg Route: NGT Frequency: BID Anticonvulsant Unknown may inhibit nerve impulses by limiting influx of sodium ions across cell membrane in motor cortex Adjunctive therapy in partial onset seizures Hypersensitivity to medication HEMA: Lowered Hct, Hgb, RBC, Infection CNS: Dizziness Somnolence Asthenia MISC: Infection Abdominal pain Pharyngitis Observe 10 rights in administering medication. Assess:
Renal Studies: Urinalysis, BUN, Urine creatinine every 3 months Blood Studies: RBC, Hct, Hgb,
WBC
Teach/Instruct Family:
Not to discontinue medication quickly after long-term use Evaluate: Therapeutic response (decreased seizure activity document on patients chart)